CN Stock MarketDetailed Quotes
300119 Tianjin Ringpu Bio-Technology
- 20.38
- +0.34+1.70%
Market Closed Dec 11 15:00 CST
9.49BMarket Cap22.40P/E (TTM)
20.70High20.00Low51.25KlotVolume20.00Open20.04Pre Close104.73MTurnover1.53%Turnover Ratio20.97P/E (Static)465.85MShares21.2552wk High2.09P/B6.83BFloat Cap11.1552wk Low24.05Limit Up334.98MShs Float43.36Historical High16.03Limit Down3.49%Amplitude3.91Historical Low0.40Dividend TTM20.44Avg Price21.50KlotAsk1.96%Div YieldTTM100Lot Size27.24KlotBid
Tianjin Ringpu Bio-Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 10.06%1.75B | 10.56%1.1B | 20.42%533.2M | 7.90%2.25B | 7.48%1.59B | 9.44%994.1M | 13.30%442.78M | 3.84%2.08B | -1.48%1.48B | -12.72%908.34M |
| Operating revenue | 10.06%1.75B | 10.56%1.1B | 20.42%533.2M | 7.90%2.25B | 7.48%1.59B | 9.44%994.1M | 13.30%442.78M | 3.84%2.08B | -1.48%1.48B | -12.72%908.34M |
| Other operating revenue | ---- | 44.79%11.63M | ---- | 12.29%24.08M | ---- | -0.26%8.03M | ---- | 6.00%21.44M | ---- | -25.11%8.05M |
| Total operating cost | 11.60%1.47B | 12.91%930.26M | 20.47%435.87M | 8.22%1.87B | 8.17%1.31B | 9.02%823.89M | 15.39%361.81M | 4.84%1.73B | 4.09%1.22B | -5.70%755.69M |
| Operating cost | 13.55%884.01M | 18.52%565.79M | 28.40%278.73M | 5.29%1.13B | 0.83%778.54M | 1.84%477.38M | 9.77%217.07M | 11.09%1.07B | 7.63%772.16M | -4.31%468.74M |
| Operating tax surcharges | 10.74%16.77M | 13.16%11.59M | 13.41%4.18M | 8.84%22.2M | 15.88%15.14M | 10.54%10.24M | 24.48%3.69M | 7.51%20.4M | 1.40%13.07M | -3.98%9.26M |
| Operating expense | 7.94%287.79M | 2.15%180.18M | 1.56%71.29M | 7.81%370.96M | 8.60%266.62M | 9.07%176.39M | 16.23%70.19M | -9.19%344.07M | 7.57%245.51M | -2.90%161.73M |
| Administration expense | 8.13%124.97M | 7.15%78.87M | 19.33%40.18M | 10.47%157.78M | 17.39%115.57M | 23.09%73.6M | 16.99%33.67M | -4.97%142.82M | -8.59%98.45M | -16.98%59.8M |
| Financial expense | 26.35%18.12M | 11.38%10.35M | -1.19%5.07M | 9.18%18.94M | 24.88%14.34M | 37.98%9.29M | 140.15%5.13M | -7.65%17.35M | -24.78%11.48M | -30.74%6.73M |
| -Interest expense (Financial expense) | 18.28%21.72M | 8.27%13.33M | -0.07%6.35M | -14.45%24.33M | -12.73%18.36M | -6.51%12.31M | 15.07%6.35M | 19.36%28.43M | 22.47%21.04M | 23.21%13.17M |
| -Interest Income (Financial expense) | 8.10%-3.8M | 1.22%-2.91M | 10.27%-1.36M | 49.87%-5.61M | 55.98%-4.13M | 55.09%-2.94M | 56.72%-1.52M | -92.97%-11.2M | -283.68%-9.39M | -371.58%-6.55M |
| Research and development | 8.84%135.16M | 8.44%83.48M | 13.60%36.42M | 30.35%172.94M | 66.84%124.18M | 55.73%76.99M | 48.77%32.06M | 12.74%132.68M | -13.22%74.43M | -7.75%49.44M |
| Credit Impairment Loss | 14.11%-18.43M | -1.71%-9.27M | -19.86%-5.54M | -54.60%-28.98M | -19.34%-21.45M | 14.01%-9.12M | 38.85%-4.62M | 7.97%-18.74M | -0.65%-17.98M | 24.42%-10.6M |
| Asset Impairment Loss | -59.09%382.17K | -50.51%382.17K | -88.35%63.09K | 22.54%580.19K | -26.17%934.21K | 46.63%772.15K | 119.99%541.39K | 155.53%473.47K | 199.15%1.27M | 215.91%526.61K |
| Other net revenue | -55.34%24.09M | -55.55%20.31M | -54.21%8.04M | 196.33%190.6M | 134.49%53.95M | 183.26%45.68M | 136.71%17.57M | -55.40%64.32M | -20.92%23.01M | 1.87%16.13M |
| Fair value change income | -21.13%23.49M | -32.19%14.89M | -31.05%10.18M | 19.22%61.26M | 61.69%29.78M | 101.70%21.96M | 78.83%14.76M | -54.85%51.38M | 120.79%18.42M | 69.55%10.89M |
| Invest income | -93.31%1.58M | -92.32%1.64M | 110.29%30.95K | 274.01%15.15M | 1,376.79%23.6M | 775.40%21.39M | -138.78%-300.77K | -78.06%4.05M | -88.74%1.6M | -82.06%2.44M |
| -Including: Investment income associates | -93.90%1.43M | -92.88%1.52M | 75.30%-88.61K | 2,477.86%21.35M | 1,974.61%23.43M | 30,948.85%21.31M | -19.53%-358.77K | -81.52%828.4K | -610.92%-1.25M | 122.28%68.64K |
| Asset deal income | -93.87%8.43K | -101.00%-764.95 | ---716.85 | 1,633,310.00%114.09M | 81.78%137.38K | --76.7K | ---- | -107.11%-6.99K | -25.72%75.58K | ---- |
| Other revenue | -18.56%17.06M | 19.50%12.66M | -53.88%3.31M | 4.93%28.5M | 6.75%20.95M | -17.67%10.6M | 25.94%7.19M | -17.83%27.16M | -17.87%19.63M | 26.58%12.87M |
| Operating profit | -6.93%304.08M | -12.42%189.08M | 6.94%105.38M | 35.66%565.23M | 14.77%326.72M | 27.92%215.89M | 16.39%98.53M | -16.57%416.64M | -21.09%284.67M | -33.85%168.77M |
| Add:Non operating Income | 166.82%1.31M | 794.82%1.03M | 244.82%369.73K | -13.58%2.96M | -84.34%489.38K | -95.61%115.51K | -92.63%107.22K | 14.98%3.42M | 155.62%3.12M | 1,990.27%2.63M |
| Less:Non operating expense | 175.88%3.1M | 100.50%1.8M | 45.52%666.68K | -75.86%1.51M | -60.73%1.12M | -59.71%899.43K | -23.59%458.15K | -57.04%6.25M | -13.58%2.86M | 21.68%2.23M |
| Total profit | -7.30%302.29M | -12.46%188.31M | 7.02%105.08M | 36.94%566.68M | 14.44%326.09M | 27.15%215.11M | 14.81%98.18M | -15.17%413.81M | -20.55%284.93M | -33.25%169.17M |
| Less:Income tax cost | 22.20%38.11M | -5.23%20.5M | 8.36%11.57M | 39.01%55.66M | 7.84%31.18M | 38.80%21.63M | 80.18%10.68M | -26.12%40.04M | -25.56%28.92M | -46.15%15.59M |
| Net profit | -10.42%264.18M | -13.27%167.81M | 6.86%93.5M | 36.72%511.02M | 15.19%294.9M | 25.97%193.47M | 9.94%87.5M | -13.80%373.77M | -19.94%256.02M | -31.58%153.59M |
| Net profit from continuing operation | -10.42%264.18M | -13.27%167.81M | 6.86%93.5M | 36.72%511.02M | 15.19%294.9M | 25.97%193.47M | 9.94%87.5M | -13.80%373.77M | -19.94%256.02M | -31.58%153.59M |
| Less:Minority Profit | -8.29%19.45M | -42.98%8.67M | -11.17%5.93M | 114.53%58.07M | -7.79%21.2M | 10.52%15.2M | -9.53%6.68M | 30.12%27.07M | -16.71%23M | -34.20%13.76M |
| Net profit of parent company owners | -10.58%244.74M | -10.73%159.14M | 8.35%87.57M | 30.64%452.94M | 17.46%273.7M | 27.49%178.27M | 11.93%80.82M | -16.01%346.7M | -20.25%233.02M | -31.32%139.83M |
| Earning per share | ||||||||||
| Basic earning per share | -9.95%0.5313 | -10.07%0.3456 | 9.13%0.1901 | 30.50%0.9772 | 17.16%0.59 | 27.00%0.3843 | 11.38%0.1742 | -27.00%0.7488 | -31.56%0.5036 | -40.98%0.3026 |
| Diluted earning per share | -9.95%0.5313 | -10.07%0.3456 | 9.13%0.1901 | 30.50%0.9772 | 17.16%0.59 | 27.00%0.3843 | 11.38%0.1742 | -27.00%0.7488 | -31.56%0.5036 | -40.98%0.3026 |
| Other composite income | ||||||||||
| Total composite income | -10.42%264.18M | -13.27%167.81M | 6.86%93.5M | 36.72%511.02M | 15.19%294.9M | 25.97%193.47M | 9.94%87.5M | -13.80%373.77M | -19.94%256.02M | -31.58%153.59M |
| Total composite income of parent company owners | -10.58%244.74M | -10.73%159.14M | 8.35%87.57M | 30.64%452.94M | 17.46%273.7M | 27.49%178.27M | 11.93%80.82M | -16.01%346.7M | -20.25%233.02M | -31.32%139.83M |
| Total composite income of minority owners | -8.29%19.45M | -42.98%8.67M | -11.17%5.93M | 114.53%58.07M | -7.79%21.2M | 10.52%15.2M | -9.53%6.68M | 30.12%27.07M | -16.71%23M | -34.20%13.76M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
